Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Personalis Inc (PSNL)

Personalis Inc (PSNL)
3.75 +0.34 (+9.97%) 09:50 ET [NASDAQ]
3.70 x 100 3.75 x 900
Realtime by (Cboe BZX)
3.70 x 100 3.75 x 900
Realtime 3.67 +0.26 (+7.62%) 08:56 ET
Quote Overview for Wed, Apr 23rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
3.61
Day High
3.78
Open 3.61
Previous Close 3.41 3.41
Volume 69,025 69,025
Avg Vol 652,847 652,847
Stochastic %K 67.04% 67.04%
Weighted Alpha -40.33 -40.33
5-Day Change +0.52 (+15.95%) +0.52 (+15.95%)
52-Week Range 1.13 - 7.20 1.13 - 7.20
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 301,130
  • Shares Outstanding, K 88,308
  • Annual Sales, $ 84,610 K
  • Annual Income, $ -81,280 K
  • EBIT $ -68 M
  • EBITDA $ -60 M
  • 60-Month Beta 1.89
  • Price/Sales 3.30
  • Price/Cash Flow N/A
  • Price/Book 1.10

Options Overview Details

View History
  • Implied Volatility 258.89% ( +0.58%)
  • Historical Volatility 91.45%
  • IV Percentile 85%
  • IV Rank 30.44%
  • IV High 739.47% on 05/23/24
  • IV Low 48.57% on 07/12/24
  • Put/Call Vol Ratio 0.01
  • Today's Volume 107
  • Volume Avg (30-Day) 67
  • Put/Call OI Ratio 0.58
  • Today's Open Interest 2,562
  • Open Int (30-Day) 4,305

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.23
  • Number of Estimates 2
  • High Estimate -0.23
  • Low Estimate -0.23
  • Prior Year -0.26
  • Growth Rate Est. (year over year) +11.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.83 +33.57%
on 04/07/25
Period Open: 3.56
3.92 -3.57%
on 03/24/25
+0.22 (+6.18%)
since 03/21/25
3-Month
2.83 +33.57%
on 04/07/25
Period Open: 6.15
6.43 -41.21%
on 02/18/25
-2.37 (-38.54%)
since 01/23/25
52-Week
1.13 +233.04%
on 07/01/24
Period Open: 1.38
7.20 -47.50%
on 08/16/24
+2.40 (+173.91%)
since 04/23/24

Most Recent Stories

More News
Personalis: Q4 Earnings Snapshot

Personalis: Q4 Earnings Snapshot

PSNL : 3.75 (+9.97%)
Oncology Experts Predict 2025 Will Be a Year of Breakthroughs in Treatment and Prevention

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – One of the largest and most advanced cancer research and treatment organizations in the USA, City of Hope,...

ONCY : 0.6004 (+0.37%)
GH : 46.64 (+6.48%)
LEGN : 35.11 (+1.83%)
PSNL : 3.75 (+9.97%)
GRAL : 35.38 (+19.16%)
ONC.TO : 0.82 (-2.38%)
Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:CRDF),(NASDAQ:PSNL),(NASDAQ:TEM),(NASDAQ:CKPT) EQNX::TICKER_END

ONCY : 0.6004 (+0.37%)
CKPT : 4.05 (+0.25%)
PSNL : 3.75 (+9.97%)
ONC.TO : 0.82 (-2.38%)
TEM : 49.38 (+14.23%)
CRDF : 3.22 (+5.57%)
Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses

/CNW/ -- USA News Group News Commentary – The American Cancer Society has published its Advances in Oncology – 2024 Research Highlights, underscoring major...

ONCY : 0.6004 (+0.37%)
CKPT : 4.05 (+0.25%)
PSNL : 3.75 (+9.97%)
ONC.TO : 0.82 (-2.38%)
TEM : 49.38 (+14.23%)
CRDF : 3.22 (+5.57%)
Early-Onset Cancer Trends Spark Interest in Promising Oncology Pipelines

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – The American Cancer Society has unveiled its Advances in Oncology – 2024 Research Highlights report,...

ONCY : 0.6004 (+0.37%)
PSNL : 3.75 (+9.97%)
ALXO : 0.6413 (+8.16%)
ONC.TO : 0.82 (-2.38%)
NVCT : 9.55 (+3.02%)
TEM : 49.38 (+14.23%)
Personalis: Q3 Earnings Snapshot

Personalis: Q3 Earnings Snapshot

PSNL : 3.75 (+9.97%)
Why Tempus AI Stock Skyrocketed Nearly 22% Today

It deepened its involvement in a client and peer.

PSNL : 3.75 (+9.97%)
TEM : 49.38 (+14.23%)
Personalis: Q2 Earnings Snapshot

Personalis: Q2 Earnings Snapshot

PSNL : 3.75 (+9.97%)
Personalis: Q1 Earnings Snapshot

Personalis: Q1 Earnings Snapshot

PSNL : 3.75 (+9.97%)
Personalis: Q4 Earnings Snapshot

Personalis: Q4 Earnings Snapshot

PSNL : 3.75 (+9.97%)

Business Summary

Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.

See More

Key Turning Points

3rd Resistance Point 3.82
2nd Resistance Point 3.66
1st Resistance Point 3.53
Last Price 3.75
1st Support Level 3.24
2nd Support Level 3.08
3rd Support Level 2.95

See More

52-Week High 7.20
Fibonacci 61.8% 4.88
Fibonacci 50% 4.17
Last Price 3.75
Fibonacci 38.2% 3.45
52-Week Low 1.13

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro